Cited 2 times in
Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정수진 | - |
dc.date.accessioned | 2022-12-22T02:23:27Z | - |
dc.date.available | 2022-12-22T02:23:27Z | - |
dc.date.issued | 2022-06 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/191559 | - |
dc.description.abstract | Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients' care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | Korean, English | - |
dc.publisher | 대한감염학회 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Mi Young Kwak | - |
dc.contributor.googleauthor | Eun Young Jo | - |
dc.contributor.googleauthor | BumSik Chin | - |
dc.contributor.googleauthor | Se Eun Park | - |
dc.contributor.googleauthor | Jun Yim | - |
dc.contributor.googleauthor | Jung Eun Lee | - |
dc.contributor.googleauthor | Kyung Eun Jo | - |
dc.contributor.googleauthor | Yeon-Sook Kim | - |
dc.contributor.googleauthor | Jeong Eun Lee | - |
dc.contributor.googleauthor | Young Kyung Yoon | - |
dc.contributor.googleauthor | Yu Bin Seo | - |
dc.contributor.googleauthor | Su Jin Jeong | - |
dc.contributor.googleauthor | Yu Min Kang | - |
dc.contributor.googleauthor | Eun-Jeong Joo | - |
dc.contributor.googleauthor | Jong Hyun Yoon | - |
dc.contributor.googleauthor | Sun Bean Kim | - |
dc.contributor.googleauthor | Ga Yeon Kim | - |
dc.contributor.googleauthor | Min-Kyung Kim | - |
dc.identifier.doi | 10.3947/IC.2022.0026 | - |
dc.contributor.localId | A03638 | - |
dc.relation.journalcode | J01053 | - |
dc.identifier.eissn | 2092-6448 | - |
dc.identifier.pmid | 35794720 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | Clinical pathways | - |
dc.subject.keyword | Hospitals, public | - |
dc.subject.keyword | Pandemics | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.contributor.alternativeName | Jeong, Su Jin | - |
dc.contributor.affiliatedAuthor | 정수진 | - |
dc.citation.volume | 54 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 353 | - |
dc.citation.endPage | 359 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, Vol.54(2) : 353-359, 2022-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.